BNP Paribas Financial Markets’s OptiNose OPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-120
| Closed | -$1.1K | – | 5600 |
|
|
2025
Q1 | $1.1K | Sell |
120
-6
| -5% | -$38 | ﹤0.01% | 5059 |
|
|
2024
Q4 | $842 | Sell |
126
-1
| -0.8% | -$9 | ﹤0.01% | 5109 |
|
|
2024
Q3 | $1.28K | Hold |
127
| – | – | ﹤0.01% | 3922 |
|
|
2024
Q2 | $1.98K | Sell |
127
-11,774
| -99% | -$197K | ﹤0.01% | 3813 |
|
|
2024
Q1 | $261K | Sell |
11,901
-435
| -4% | -$9.65K | ﹤0.01% | 3163 |
|
|
2023
Q4 | $239K | Buy |
12,336
+8,001
| +185% | +$146K | ﹤0.01% | 3135 |
|
|
2023
Q3 | $80K | Buy |
4,335
+3,030
| +232% | +$54.5K | ﹤0.01% | 3383 |
|
|
2023
Q2 | $24.1K | Buy |
1,305
+1,199
| +1,131% | +$28.4K | ﹤0.01% | 3572 |
|
|
2023
Q1 | $3.07K | Sell |
106
-6
| -5% | -$160 | ﹤0.01% | 3614 |
|
|
2022
Q4 | $3.12K | Buy |
112
+60
| +115% | +$2.28K | ﹤0.01% | 3703 |
|
|
2022
Q3 | $2.88K | Sell |
52
-77
| -60% | -$4.23K | ﹤0.01% | 4306 |
|
|
2022
Q2 | $7.1K | Buy |
129
+67
| +108% | +$2.46K | ﹤0.01% | 3785 |
|
|
2022
Q1 | $2.29K | Hold |
62
| – | – | ﹤0.01% | 3894 |
|
|
2021
Q4 | $1.5K | Hold |
62
| – | – | ﹤0.01% | 4022 |
|
|
2021
Q3 | $2.77K | Sell |
62
-13
| -17% | -$545 | ﹤0.01% | 3760 |
|
|
2021
Q2 | $3.52K | Sell |
75
-253
| -77% | -$12.9K | ﹤0.01% | 3829 |
|
|
2021
Q1 | $18.2K | Sell |
328
-201
| -38% | -$12.2K | ﹤0.01% | 3773 |
|
|
2020
Q4 | $32.8K | Sell |
529
-98
| -16% | -$6K | ﹤0.01% | 3721 |
|
|
2020
Q3 | $36.7K | Buy |
627
+377
| +151% | +$27.9K | ﹤0.01% | 3603 |
|
|
2020
Q2 | $27.9K | Sell |
250
-286
| -53% | -$20.4K | ﹤0.01% | 3262 |
|
|
2020
Q1 | $36.1K | Buy |
536
+341
| +175% | +$34.3K | ﹤0.01% | 3703 |
|
|
2019
Q4 | $26.9K | Sell |
195
-30
| -13% | -$3.89K | ﹤0.01% | 3917 |
|
|
2019
Q3 | $23.6K | Buy |
225
+81
| +56% | +$8.09K | ﹤0.01% | 3878 |
|
|
2019
Q2 | $15.3K | Sell |
144
-123
| -46% | -$16.2K | ﹤0.01% | 3994 |
|
|
2019
Q1 | $41.3K | Buy |
267
+251
| +1,569% | +$29.1K | ﹤0.01% | 3609 |
|
|
2018
Q4 | $1.49K | Sell |
16
-19
| -54% | -$2.71K | ﹤0.01% | 3856 |
|
|
2018
Q3 | $6.58K | Sell |
35
-24
| -41% | -$6.84K | ﹤0.01% | 3927 |
|
|
2018
Q2 | $24.7K | Sell |
59
-4
| -6% | -$1.35K | ﹤0.01% | 3411 |
|
|
2018
Q1 | $18.9K | Buy |
63
+7
| +13% | +$1.94K | ﹤0.01% | 3936 |
|
|
2017
Q4 | $16K | Buy |
+56
| New | +$15.8K | ﹤0.01% | 3985 |
|
BNP Paribas Financial Markets's OPTN Position: Q2 2025 in Review
BNP Paribas Financial Markets sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 120 shares — an estimated $1.1K sold.
BNP Paribas Financial Markets first reported a position in OPTN in Q4 2017 and held it in 30 quarters. The position peaked at $261K in Q1 2024. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.
- BNP Paribas Financial Markets reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
- BNP Paribas Financial Markets sold 120 OptiNose shares in Q2 2025, an estimated $1.1K.
- BNP Paribas Financial Markets first reported a position in OptiNose in Q4 2017 and held it in 30 quarters.
- BNP Paribas Financial Markets's OptiNose position peaked at $261K in Q1 2024.
- 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2025, filed 14 Aug 2025.